$荃信生物-B(02_老虎社区_美港股上老虎

$荃信生物-B(02509)$ 有新进展，靶向IL-23p19和TL1A的双抗QX030N/CLD-423，已经给首批健康志愿者用药，正式进入I期临床啦，这药瞄准炎症性肠病，双靶点协同起效，潜力不小呢。

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

推荐
最新

暂无评论

热议股票

{"i18n":{"language":"zh_CN"},"data":{"magic":2,"id":522268611646640,"tweetId":"522268611646640","gmtCreate":1768542952961,"gmtModify":1768542956182,"author":{"id":4215846347868680,"idStr":"4215846347868680","authorId":4215846347868680,"authorIdStr":"4215846347868680","name":"九月168","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":1,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"title":"","html":"<html><head></head><body><p><a href=\"https://laohu8.com/S/02509\">$荃信生物-B(02509)$ </a> 有新进展，靶向IL-23p19和TL1A的双抗QX030N/CLD-423，已经给首批健康志愿者用药，正式进入I期临床啦， 这药瞄准炎症性肠病，双靶点协同起效，潜力不小呢。</p></body></html>","htmlText":"<html><head></head><body><p><a href=\"https://laohu8.com/S/02509\">$荃信生物-B(02509)$ </a> 有新进展，靶向IL-23p19和TL1A的双抗QX030N/CLD-423，已经给首批健康志愿者用药，正式进入I期临床啦， 这药瞄准炎症性肠病，双靶点协同起效，潜力不小呢。</p></body></html>","text":"$荃信生物-B(02509)$ 有新进展，靶向IL-23p19和TL1A的双抗QX030N/CLD-423，已经给首批健康志愿者用药，正式进入I期临床啦， 这药瞄准炎症性肠病，双靶点协同起效，潜力不小呢。","highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/522268611646640","repostId":0,"isVote":1,"tweetType":1,"viewCount":19,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["02509"],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":155,"optionInvolvedFlag":false,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"hasMoreComment":false,"orderType":2}